Open AccessEndoscopic management of duodenal levodopa-carbidopa therapy of advanced Parkinson�s disease
Author(s) -
Carmen Garrido Durán,
Sam Khorrami Minaei,
P Sendra Rumbeu,
Joaquín Fernández García,
Marcelo García Hernández,
I. Legarda Ramírez
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6311/2019
Subject(s) - medicine , percutaneous endoscopic gastrostomy , adverse effect , carbidopa , levodopa , surgery , retrospective cohort study , comorbidity , parkinson's disease , disease , pediatrics , peg ratio , finance , economics
treatment of intraduodenal levodopa using percutaneous endoscopic gastrostomy is an alternative therapy in patients with advanced Parkinson's disease. There are few studies that have evaluated the endoscopic aspects of this technique.